跳至主要内容
临床试验/IRCT20180903040941N1
IRCT20180903040941N1招募中未知

The effect of Matricaria chamomilla L. on insulin resistance, inflammatory status and other related indices in patients with non-alcoholic fatty liver

Fasa University of Medical Sciences0 个研究点目标入组 44 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
44

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
25 years 至 65 years(—)
性别
All

入选标准

  • sign the consent form
  • age between 25-65 years
  • BMI between 22-35
  • Diagnosis of fatty liver and steatohepatitis with: A- serum level of Alanine Transaminease (ALT) More than one and a half times the highest normal limit(66/5000This means that more than 45 men and women more than or equal to 29 units per liter)Also, the amount of aspartate transaminase (AST) In both sexes is greater than 30 units per liter(According to the latest definition of ALT and abnormal AST in men and women). B- Diagnosis of fatty liver (moderate to high) in liver ultrasound.
  • The patient have not to consume lipid regulating drugs for four weeks
  • The patient have not to consume some drugs like silybin, ursodeoxycholic acid, Polyene Phosphatidylcholine, vitamin E and Medicinal herbs with blood lipid regulation effect and hepatoprotective effect from four weeks bfore entering to the study.

排除标准

  • pregnancy and lactation
  • Liver failure (acute or chronic)
  • Liver diseases such as autoimmune hepatitis, viral hepatitis B and C (active or inactive), Wilson's disease and etc.
  • Hypo and hyperthyroidism
  • Renal failure (creatinine above 1.5 mg / dL)
  • Any malignancy (treated or not)
  • Taking warfarin
  • Addiction and alcohol consumption
  • Taking contraceptives, ouroso-doxycyclic acid, glucocorticoid, statins, probiotics, vitamin E over the past three months
  • Chamomile allergy history

研究者

发起方
Fasa University of Medical Sciences

相似试验